BioSpace News Archive

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food Drug and Administration (FDA) granted Orphan Drug Designation for TP-3654, the company’s proprietary investigational oral inhibitor of PIM kinases, for the treatment of myelofibrosis.

Eiger BioPharmaceuticals, Inc. today announced four abstracts to be presented at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022 taking place June 22-26 in London, United Kingdom.

Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022.

Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) and Ultima Genomics (“Ultima”) today announced that they have entered into a collaboration to enable the use of the Olink® Explore high-throughput proteomics platform with Ultima’s sequencing architecture.

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that management will be participating in the JMP Securities Life Sciences Conference being held June 15-16, 2022 in New York City.

Regulatory milestone to accelerate company’s international growth amid expanding presence in Europe.

Company to present preclinical metabolomic data on one of its HSD17B13 inhibitors at the International Liver Congress™ 2022.

This approval from U.S. FDA enables Gannex to complete a critical drug-drug interaction (DDI) study to support upcoming Phase III trials in China, the U.S. and European Union.

Affini-T Therapeutics, Inc. , a biotechnology company unlocking the power of T cells against oncogenic driver mutations, today announced three presentations at upcoming investor and industry conferences.

The Parker Institute for Cancer Immunotherapy and National Resilience, Inc. announced the launch of a five-year strategic alliance to develop next-generation cancer therapies generated from PICI’s network of leading immunotherapy research centers.